- Home
- SMG vs DNLI Comparison
SMG vs DNLI Comparison
Compare SMG & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMG | DNLI |
|---|---|---|
| Founded | 1868 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 2012 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SMG | DNLI |
|---|---|---|
| Price | $59.47 | $19.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 20 |
| Target Price | ★ $72.83 | $35.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.45% | N/A |
| EPS Growth | ★ 504.92 | N/A |
| EPS | ★ 3.82 | N/A |
| Revenue | ★ $3,016,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.23 | $157.92 |
| P/E Ratio | $15.50 | ★ N/A |
| Revenue Growth | ★ 6.17 | N/A |
| 52 Week Low | $47.90 | $13.75 |
| 52 Week High | $75.34 | $27.30 |
Technical Indicators
Market Signals| Indicator | SMG | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 68.32 | 45.98 |
| Support Level | $58.59 | $17.75 |
| Resistance Level | $63.66 | $19.35 |
| Average True Range (ATR) | 1.74 | 0.77 |
| MACD | 1.09 | 0.19 |
| Stochastic Oscillator | 95.23 | 71.62 |
Price Performance
Historical ComparisonAbout SMG Scotts Miracle-Gro Company (The)
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat. Over half of revenue typically comes from Home Depot and Lowe's, as Scotts' products are featured at both home improvement retailers.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.